D
Daniel Engelbert Blockmans
Researcher at Katholieke Universiteit Leuven
Publications - 233
Citations - 12902
Daniel Engelbert Blockmans is an academic researcher from Katholieke Universiteit Leuven. The author has contributed to research in topics: Giant cell arteritis & Vasculitis. The author has an hindex of 46, co-authored 211 publications receiving 10750 citations. Previous affiliations of Daniel Engelbert Blockmans include Universitaire Ziekenhuizen Leuven.
Papers
More filters
Journal ArticleDOI
Immunosuppressive therapy in lupus nephritis: the Euro-Lupus Nephritis Trial, a randomized trial of low-dose versus high-dose intravenous cyclophosphamide.
Frédéric Houssiau,Carlos Vasconcelos,David D'Cruz,Gian Domenico Sebastiani,Enrique de Ramón Garrido,Maria Giovanna Danieli,Daniel Abramovicz,Daniel Engelbert Blockmans,Alessandro Mathieu,Haner Direskeneli,Mauro Galeazzi,Ahmet Gül,Yair Levy,Peter Petera,Rajko Popovic,Radmila Petrovic,Renato Alberto Sinico,Roberto Cattaneo,Josep Font,Geneviève Depresseux,Jean-Pierre Cosyns,Ricard Cervera +21 more
TL;DR: The data from the ELNT indicate that in European SLE patients with proliferative lupus nephritis, a remission-inducing regimen of low-dose IV CYC (cumulative dose 3 gm) followed by AZA achieves clinical results comparable to those obtained with a high-dose regimen.
Journal ArticleDOI
Trial of Tocilizumab in Giant-Cell Arteritis.
John H. Stone,Katie Tuckwell,Sophie Dimonaco,Micki Klearman,Martin Aringer,Daniel Engelbert Blockmans,Elisabeth Brouwer,Maria C. Cid,Bhaskar Dasgupta,Juergen Rech,Carlo Salvarani,Georg Schett,Hendrik Schulze-Koops,Robert Spiera,Sebastian Unizony,Neil Collinson +15 more
TL;DR: Tocilizumab, received weekly or every other week, combined with a 26‐week prednisone taper was superior to either 26‐ week or 52‐weekprednisone tapering plus placebo with regard to sustained glucocorticoid‐free remission in patients with giant‐cell arteritis.
Journal ArticleDOI
EULAR recommendations for the use of imaging in large vessel vasculitis in clinical practice.
Christian Dejaco,Sofia Ramiro,Christina Duftner,Florent L. Besson,Thorsten A. Bley,Daniel Engelbert Blockmans,Elisabeth Brouwer,Marco A. Cimmino,Eric Clark,Bhaskar Dasgupta,Bhaskar Dasgupta,Andreas P. Diamantopoulos,Haner Direskeneli,Annamaria Iagnocco,Thorsten Klink,Lorna Neill,Cristina Ponte,Carlo Salvarani,Riemer H. J. A. Slart,Madeline Whitlock,Wolfgang A. Schmidt +20 more
TL;DR: The task force recommends an early imaging test in patients with suspected LVV, with ultrasound and MRI being the first choices in GCA and TAK, respectively, which are the first EULAR recommendations providing up-to-date guidance for the role of imaging in the diagnosis and monitoring of patients with (suspected) LVV.
Journal ArticleDOI
Antineutrophil Cytoplasmic Antibodies and the Churg–Strauss Syndrome
Régis Sablé-Fourtassou,Pascal Cohen,Alfred Mahr,Christian Pagnoux,Luc Mouthon,David Jayne,Daniel Engelbert Blockmans,Jean-François Cordier,Philippe Delaval,Xavier Puéchal,Dominique Lauque,Jean-François Viallard,Abdelkader Zoulim,Loïc Guillevin +13 more
TL;DR: The clinical characteristics of patients who recently received a diagnosis of the ChurgStrauss syndrome and who were included in prospective therapeutic trials organized by the French Vasculitis Study Group (FVSG) and the EUVAS were described to compare the characteristics of Patients with and without ANCA.
Journal ArticleDOI
Repetitive 18F-fluorodeoxyglucose positron emission tomography in giant cell arteritis: a prospective study of 35 patients.
Daniel Engelbert Blockmans,Liesbet De Ceuninck,Steven Vanderschueren,Daniel Knockaert,Luc Mortelmans,Herman Bobbaers +5 more
TL;DR: FDG uptake in the large vessels is a sensitive marker for GCA, which can involve the larger thoracic, abdominal, and peripheral arteries, and relapse cannot be predicted by results of former PET scintigraphies.